Выявление факторов формирования фолликулов в яичниках детей: кисспептина, рецептора кисспептина, ароматазы, рецептора антимюллерова гормона

1. Abbara A., Jayasena C. N., Christopoulos G., Narayanaswamy S. 2015. “Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) during in Vitro Fertilization (IVF) Therapy.” Journal of Clinical Endocrinology and Metabolism 100(9): 3322-31.
2. Adashi E.Y. and A.W. Hsueh. 1982. “Estrogens Augment the Stimulation of Ovarian Aromatase Activity by Follicle-Stimulating Hormone in Cultured Rat Granulosa Cells.” Journal of Biological Chemistry 257(11): 6077-83.
3. Allard S., Adin P., Gouedard L. 2000. “Molecular Mechanisms of Hormone - Mediated Mullerian Duct Regression: Involvement of Beta-Catenin.” Development (Cambridge, England) 127(15): 3349-60.
4. Amaranth B., Corbin Jo, Peterson A. 1993. “Functional Domains of Human Aromatase Cytochrome P450 Characterized by Linear Alignment and Site- Directed Mutagenesis.” Molecular Endocrinology (Baltimore, Md.) 7(12): 1617¬24.
5. Anttonen M. and Farkilla A. 2011. “Anti-Mullerian Hormone Inhibits Growth
of AMH Type II Receptor-Positive Human Ovarian Granulosa Cell Tumor Cells by Activating Apoptosis.” Laboratory Investigation 91(11): 1605-14.
6. Britt K. L., Drummond A. E., Cox V. A. 2000. “An Age-Related Ovarian Phenotype in Mice with Targeted Disruption of the Cyp 19 (Aromatase) Gene.” Endocrinology 141(7): 2614-23.
7. Cate R. L., Mattaliano R. J., Hesston S. 1986. “Isolation of the Bovine and Human Genes for Mullerian Inhibiting Substance and Expression of the Human Gene in Animal Cells.” Cell 45(5): 685-98.
8. Cejudo Roman A., Pinto F. M., Dorta I. P. 2012. “Analysis of the Expression of Neurokinin B, Kisspeptin, and Their Cognate Receptors NK3R and KISS1R in the Human Female Genital Tract.” Fertility and Sterility 97(5): 1213-19.
9. Chen S. M., J. Berman, Sparklers R. S. 1988. “Human Aromatase: cDNA Cloning, Southern Blot Analysis, and Assignment of the Gene to Chromosome 15.” DNA 7(1): 27-38
10. Clarke T. R., Hoshiya Y., Soyun E. “Mullerian Inhibiting Substance Signaling Uses a Bone Morphogenetic Protein (BMP)-Like Pathway Mediated by ALK2 and Induces Smad6 Expression.” Molecular endocrinology (Baltimore, Md.) 15(6): 946-59.
11. Di Clemente N., N. Josso, L. Gouedard and C. Belville. 2003. “Components of the Anti-Mullerian Hormone Signaling Pathway in Gonads.” Molecular and Cellular Endocrinology 211(1-2): 9-14.
12. Conte F. A., Crumbach M. M., Ito Y. 1994. “A Syndrome of Female Pseudohermaphrodism, Hypergonadotropic Hypogonadism, and Multicystic Ovaries Associated with Missense Mutations in the Gene Encoding Aromatase (P450arom).” Journal of Clinical Endocrinology and Metabolism 78(6): 1287-92.
13. Couse J. F., Hewitt S. C., Bunch D. O. “Postnatal Sex Reversal of the Ovaries in Mice Lacking Estrogen Receptors Alpha and Beta.” Science 286(5448): 2328¬31.
14. Couse, John F., Mariana M. Yates, Bonnie J. Deroo and Kenneth S. Korach.
2005. “Estrogen Receptor-0 Is Critical to Granulosa Cell Differentiation and the Ovulatory Response to Gonadotropins.” Endocrinology 146(8): 3247-62.
15. Durlinger L. L., Gruijters J. G., Kramer P. 2001. “Anti-Mullerian Hormone Attenuates the Effects of FSH on Follicle Development in the Mouse Ovary.” Endocrinology 142(11): 4891-99.
16. Elvin J. A., Yan C., Wang P. 1999. “Molecular Characterization of the Follicle Defects in the Growth Differentiation Factor 9-Deficient Ovary.” Molecular Endocrinology 13(6): 1018-34.
17. Erickson G F, V G Garza and D A Magoffin. 1989. “Insulin-like Growth Factor-I Regulates Aromatase Activity in Human Granulosa and Granulosa Luteal Cells.” Journal of Clinical Endocrinology and Metabolism 69(4): 716— 24.
18. Fisher Carolyn R, Kathy H Graves, Albert F Parlor and Evan R Simpson.
1998. “Characterization of Mice Deficient in Aromatase (ArKO) because of Targeted Disruption of the cyp19 Gene.” Medical Sciences 95(June): 6965-70.
19. Fitzpatrick S L and J S Richards. 1991. “Regulation of P-450 Aromatase Messenger Ribonucleic Acid and Activity by Steroids and Gonadotropin in Rat Granulosa Cells.” Endocrinology 129(3)(3): 1452-62.
20. Forabosco A., Sforza C., Pol A. 1991. “Morphometric Study of the Human Neonatal Ovary.” The Anatomical record 231: 201-8.
21. Forabosco Antonio and Chiarella Sforza. 2007. “Establishment of Ovarian Reserve: A Quantitative Morphometric Study of the Developing Human Ovary.” Fertility and Sterility 88(3): 675-83.
22. Funes S., Hedrick J. A., Vassileva G. 2003. “The KiSS-1 Receptor GPR54 Is Essential for the Development of the Murine Reproductive System.” Biochemical and Biophysical Research Communications 312(4): 1357-63.
23. Garcia-Ortega J., Pinto F. M., Prados N. 2014. “Expression of Neurokinin B/NK3 Receptor and kisspeptin/KISS1 Receptor in Human Granulosa Cells.” Human Reproduction 29(12): 2736-46.
24. Gaytan F., Gaytan M., Castellano J. M. “KiSS-1 in the Mammalian Ovary: Distribution of Kisspeptin in Human and Marmoset and Alterations in KiSS-1 mRNA Levels in a Rat Model of Ovulatory Dysfunction.” American journal of physiology. Endocrinology and metabolism 296(3): E520-31.
25. Gerber S., Megale R., Vale F. 2012. “Variation in Ovarian Follicle Density during Human Fetal Development.” Journal of Assisted Reproduction and Genetics 29(9): 969-72.
26. George, Fredrick W., and Jean D. Wilson. 1978. “Conversion of Androgen to Estrogen by the Human Fetal Ovary.” Journal of Clinical Endocrinology and Metabolism 47(3): 550-55.
27. Ghosh, Debashis, Jennifer Griswold, Mary Erman, and Walter Pangborn.
2009. “Structural Basis for Androgen Specificity and Oestrogen Synthesis in Human Aromatase.” Nature 457(7226): 219-23.
28. Gouedard, L et al. 2000. “Engagement of Bone Morphogenetic Protein Type IB Receptor and Smadl Signaling by Anti-Mullerian Hormone and Its Type II Receptor.” The Journal of biological chemistry 275(36): 27973-78.
29. Guigon, Celine J. et al. 2003. “Unaltered Development of the Initial Follicular Waves and Normal Pubertal Onset in Female Rats alter Neonatal Deletion of the Follicular Reserve.” Endocrinology 144(8): 3651-62.
30. Hrabovszky, E. et al. 2010. “The Kisspeptin System of the Human Hypothalamus: Sexual Dimorphism and Relationship with Gonadotropin-Releasing Hormone and Neurokinin B Neurons.” European Journal of Neuroscience 31(11): 1984-98.
31. Imbeaud, S et al. 1995. “Insensitivity to Anti-Mullerian Hormone due to a Mutation in the Human Anti-Mullerian Hormone Receptor.” Nature genetics 11(4): 382-88.
32. Jamin, Soazik P et al. 2002. “Requirement of Bmprla for Mullerian Duct Regression during Male Sexual Development.” Nature genetics 32(October): 408-10.
33. Jamin, Soazik P. et al. 2003. “Genetic Studies of the AMH/MIS Signaling Pathway for Mullerian Duct Regression.” Molecular and Cellular Endocrinology 211(1-2): 15-19.
34. Jayasena, C N et al. 2010. “Twice-Weekly Administration of Kisspeptin-54 for 8 Weeks Stimulates Release of Reproductive Hormones in Women with Hypothalamic Amenorrhea.” Clinical Pharmacology & Therapeutics 88(6): 840-47.
35. Jayasena, Channa N. et al. 2009. “Subcutaneous Injection of Kisspeptin-54 Acutely Stimulates Gonadotropin Secretion in Women with Hypothalamic Amenorrhea, but Chronic Administration Causes Tachyphylaxis.” Journal of Clinical Endocrinology and Metabolism 94(11): 4315-23.
36. Kevenaar, M.E. et al. 2007. “Anti-Mullerian Hormone and Anti-Mullerian Hormone Type II Receptor Polymorphisms Are Associated with Follicular Phase Estradiol Levels in Normo-Ovulatory Women.” Human Reproduction 22(6): 1547-54.
37. Korach, Kenneth S. et al. 2003. “Update on Animal Models Developed for Analyses of Estrogen Receptor Biological Activity.” Journal of Steroid Biochemistry and Molecular Biology 86(3-5): 387-91.
38. Kotani, Masato et al. 2001. “The Metastasis Suppressor Gene KiSS-1 Encodes Kisspeptins, the Natural Ligands of the Orphan G Protein-Coupled Receptor GPR54.” Journal of Biological Chemistry 276(37): 34631-36.
39. Lee, Dennis K. et al. 1999. “Discovery of a Receptor Related to the Galanin Receptors.” FEBSLetters 446(1): 103-7.
40. Lee, J H et al. 1996. “KiSS-1, a Novel Human Malignant Melanoma Metastasis-Suppressor Gene.” Journal of the National Cancer Institute 88(23): 1731-37.
41. Lin, H Y, and H F Lodish. 1993. “Receptors for the TFG-Beta Superfamily: Multiple Polypeptides and Sering/threonine Kinases.” Trends Cell Biol 3(January): 14-19.
42. Masiakos, P T et al. 1999. “Human Ovarian Cancer, Cell Lines, and Primary Ascites Cells Express the Human Mullerian Inhibiting Substance (MIS) Type II Receptor, Bind, and Are Responsive to MIS.” Clin Cancer Res
5(11): 3488-99.
43. Mason, H D, S Cwyfan-Hughes, J M Holly, and S Franks. 1998. “Potent Inhibition of Human Ovarian Steroidogenesis by Insulin-like Growth Factor Binding Protein-4 (IGFBP-4).” The Journal of clinical endocrinology and metabolism 83(1): 284-87.
44. Mayer, Christian, and Ulrich Boehm. 2011. “Female Reproductive Maturation in the Absence of kisspeptin/GPR54 Signaling.” Nature neuroscience 14(6): 704-10.
45. Mendelson, Carole R., and Amrita Kamat. 2007. “Mechanisms in the Regulation of Aromatase in Developing Ovary and Placenta.” Journal of Steroid Biochemistry and Molecular Biology 106(1-5): 62-70.
46. Michelle L. Gottsch, Donald K Clifton, and Robert A. Steiner. 2010. “NIH Public Access.” Peptides 30(1): 4-9.
47. Min, Le et al. 2014. “Dynamic Kisspeptin Receptor Trafficking Modulates Kisspeptin-Mediated Calcium Signaling.” Molecular Endocrinology 28(1): 16-27.
48. Mishina, Yuji et al. 1996. “Genetic Analysis of the Mullerian-Inhibiting Substance Signal Transduction Pathway in Mammalian Sexual Differentiation.” Genes & development 10(20): 2577-87.
49. Muir, Alison I. et al. 2001. “AXOR12, a Novel Human G Protein-Coupled Receptor, Activated by the Peptide KiSS-1.” Journal of Biological Chemistry 276(31): 28969-75.
50. Naftolin, Frederick et al. 2007. “Estrogen-Induced Hypothalamic Synaptic Plasticity and Pituitary Sensitization in the Control of the Estrogen-Induced Gonadotrophin Surge.” Reproductive sciences (Thousand Oaks, Calif.) 14(2): 101-16.
51. Nakao, Atsuhito et al. 1997. “TGF-0 Receptor-Mediated Signalling through Smad2, Smad3 and Smad4.” EMBO Journal 16(17): 5353-62.
52. NELSON, DAVID R. et al. 1993. “The P450 Superfamily: Update on New
Sequences, Gene Mapping, Accession Numbers, Early Trivial Names of Enzymes, and Nomenclature.” DNA and Cell Biology 12(1): 1-51.
53. Ohtaki, T. et al. 2001. “Metastasis Suppressor Gene KiSS-1 Encodes Peptide Ligand of a G-Protein-Coupled Receptor.” Nature 411(6837): 613-17.
54. Otsuka, Fumio, Shin Yamamoto, Gregory F. Erickson, and Shunichi Shimasaki. 2001. “Bone Morphogenetic Protein-15 Inhibits Follicle-Stimulating Hormone (FSH) Action by Suppressing FSH Receptor Expression.” Journal of Biological Chemistry 276(14): 11387-92.
55. Rajpert-De Meyts, E et al. 1999. “Expression of Anti-Mullerian Hormone during Normal and Pathological Gonadal Development: Association with Differentiation of Sertoli and Granulosa Cells.” The Journal of clinical endocrinology and metabolism 84(10): 3836-44.
56. Rometo, Adonna M., Sally J. Krajewski, Mary Lou Voytko, and Naomi E. Rance. 2007. “Hypertrophy and Increased Kisspeptin Gene Expression in the Hypothalamic Infundibular Nucleus of Postmenopausal Women and Ovariectomized Monkeys.” Journal of Clinical Endocrinology and Metabolism 92(7): 2744-50.
57. de Roux, Nicolas et al. 2003. “Hypogonadotropic Hypogonadism due to Loss of Function of the KiSS1-Derived Peptide Receptor GPR54.” Proc. Natl. Acad. Sci. U.S.A. 100: 10972-76.
58. Salhi, Imed et al. 2004. “The Anti-Mullerian Hormone Type II Receptor: Insights into the Binding Domains Recognized by a Monoclonal Antibody and the Natural Ligand.” The Biochemical journal 379: 785-93.
59. Satoh, M. 1991. “Histogenesis and Organogenesis of the Gonad in Human
Embryos.” Journal of anatomy 177: 85-107.
60. Schomberg, D W et al. 1999. “Targeted Disruption of the Estrogen Receptor¬Alpha Gene in Female Mice: Characterization of Ovarian Responses and
Phenotype in the Adult.” Endocrinology 140(6): 2733-44.
61. Segev, Dorry L et al. 2002. “Mullerian-Inhibiting Substance Regulates NF- Kappa B Signaling in the Prostate in Vitro and in Vivo.” Proceedings of the National Academy of Sciences of the United States of America 99(1): 239-44.
62. Seminara, Stephanie B et al. 2003. “The GPR54Gene as a Regulator of
63. Puberty.” New England Journal of Medicine 349(17): 1614-27.
64. Sforza, Chiarella, Andrea Ranzi, Virgilio F. Ferrario, and Antonino Forabosco. 2004. “Growth Patterns of Human Ovarian Volume during Intrauterine and Postnatal Organogenesis.” Early Human Development 80(1): 7¬17.
65. Sforza, Chiarella, Laura Vizzotto, Virgilio F. Ferrario, and Antonino Forabosco. 2003. “Position of Follicles in Normal Human Ovary during Definitive Histogenesis.” Early Human Development 74(1): 27-35.
66. Simmons, Daniel L, Peter A Lalleytii, and Charles B Kasper. 1984. “Chromosomal Assignments of Genes Coding for Components of the Mixed- Function Oxidase System in Mice.” The Journal of biological chemistry 260(1): 515-21.
67. Simpson, Evan R. 2004. “Models of Aromatase Insufficiency.” Seminars in Reproductive Medicine 22(1): 25-30.
68. Skinner, Michael K. 2005. “Regulation of Primordial Follicle Assembly and Development.” Human Reproduction Update 11(5): 461-71.
69. Spicer, Leo J. et al. 2006. “Growth Differentiation Factor-9 Has Divergent Effects on Proliferation and Steroidogenesis of Bovine Granulosa Cells.” Journal of Endocrinology 189(2): 329-39.
70. Steinkampf, M P, C R Mendelson, and E R Simpson. 1988. “Effects of
Epidermal Growth Factor and Insulin-like Growth Factor I on the Levels of mRNA Encoding Aromatase Cytochrome P-450 of Human Ovarian Granulosa Cells.” Molecular and cellular endocrinology 59(1-2): 93-99.
54
71. Terada, N et al. 1984. “Augmentation of Aromatase-Activity by Fsh in Ovaries of Fetal and Neonatal Mice in Organ-Culture.” Journal of Steroid Biochemistry and Molecular Biology 20(3): 741-45.
72. Thompson Jr., E A, and P K Siiteri. 1974. “The Involvement of Human Placental Microsomal Cytochrome P-450 in Aromatization.” Journal of Biological Chemistry 249(176): 5373-78.
73. Turner, K J et al. 2002. “Development and Validation of a New Monoclonal Antibody to Mammalian Aromatase.” The Journal of endocrinology 172(1): 21¬
30.
74. Visser, Jenny A et al. 2001. “The Serine/threonine Transmembrane Receptor ALK2 Mediates Mullerian Inhibiting Substance Signaling.” Molecular endocrinology (Baltimore, Md.) 15(6): 936-45.
75. Visser, Jenny A., and A. P N Themmen. 2005. “Anti-Mullerian Hormone and Folliculogenesis.” Molecular and Cellular Endocrinology 234(1-2): 81-86.
76. Vitt, U A, M Hayashi, C Klein, and A J Hsueh. 2000. “Growth Differentiation
Factor-9 Stimulates Proliferation but Suppresses the Follicle-Stimulating Hormone-Induced Differentiation of Cultured Granulosa Cells from Small Antral and Preovulatory Rat Follicles.” Biology of reproduction 62(2): 370-77.
77. Wahab, F. et al. 2011. “Decrease in Hypothalamic kissl and kisslr Expression: A Potential Mechanism for Fasting-Induced Suppression of the HPG Axis in the Adult Male Rhesus Monkey (Macaca Mulatta).” Hormone and Metabolic Research 43(2): 81-85.
78. West, A, P J Vojta, D R Welch, and B E Weissman. 1998. “Chromosome Localization and Genomic Structure of the KiSS-1 Metastasis Suppressor Gene (KISS1).” Genomics 54(1): 145-48.
79. Wu, Yan-guang, Jill Bennett, Deepika Talla, and Carlos Stocco. 2011.
“Testosterone, Not 5a-Dihydrotestosterone, Stimulates LRH-1 Leading to FSH- Independent Expression of Cyp19 and P450scc in Granulosa Cells.” Molecular 55
endocrinology (Baltimore, Md.) 25(4): 656-68.
80. Yoshida, Yoko et al. 2014. “Analyzing the Possible Involvement of Anti- Mullerian Hormone and Anti-Mullerian Hormone Receptor II Single Nucleotide Polymorphism in Infertility.” Journal of Assisted Reproduction and Genetics 31(2): 163-68.
81. Young, Jacques et al. 2013. “Kisspeptin Restores Pulsatile LH Secretion in
Patients with Neurokinin B Signaling Deficiencies: Physiological,
Pathophysiological and Therapeutic Implications.” Neuroendocrinology 97(2): 193-202.
82. Zhou, Jian, T Rajendra Kumar, Martin M Matzuk, and C Bondy. 1997. “Insulin-like Growth Factor I Regulates Gonadotropin Responsiveness in the Murine Ovary.” Molecular endocrinology (Baltimore, Md.) 11(13): 1924-33.
83. Лысова. А. Н. 2015. Уровень кисспепетина у женщин с прерывание беременности в ранние сроки.” Вестник медицинского института «РЕАВИЗ» 4: 65-67.
84. Боровая, Т. Г. 2011. “Половая система.” Руководство по гистологии, глава 16, Санкт-Петербург: СпецЛит, 398-425.
85. Зарубина Е.Г. и Лысова А. Н. 2015. “Роль кисспептина в нормализации взрослых самок крыс.” Вестник медицинского института «РЕАВИЗ» 5: 65¬67.
86. О. Л. Горбунова и Ширшев С. В. 2013. “Влияние кисспептина на фуккциональную активность моноцитов.” Клеточная иммунология 5: 2-6.
87. Радзинский В. Е. 2014. Гинекология. Учебник:988.

Купить